| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.071 | 0.01 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |